Related Experiment Videos
[Longterm psychosis and sultopride]
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
|September 22, 1983
Summary
Sultopride demonstrated superior efficacy and faster action compared to phenothiazines in treating chronic psychosis patients during rehospitalization. This antipsychotic medication showed a high satisfactory response rate, improving patient outcomes.
Area of Science:
- Psychiatry and Pharmacology
Background:
- Chronic psychosis, including manic-depressive psychoses and schizophrenia, often requires rehospitalization for acute episodes.
- Phenothiazines have been a traditional treatment for psychosis, but their efficacy and speed of action can vary.
Purpose of the Study:
- To evaluate the efficacy and onset of action of sultopride as a primary therapy for chronic psychosis patients.
- To compare the effectiveness of sultopride against phenothiazines in a comparable patient group.
Main Methods:
- A study involving 22 patients with chronic psychosis (8 manic-depressive, 14 schizophrenic) undergoing rehospitalization.
- Initial treatment with sultopride at a daily dose of 4 vials, followed by oral administration after symptomatic improvement.
- Comparison of sultopride's outcomes with historical data from patients treated with phenothiazines.
Main Results:
- Sultopride achieved a satisfactory response in 81.8% of patients.
- The study found sultopride to be statistically significantly more effective than phenothiazines.
- Sultopride exhibited a more rapid onset of therapeutic action compared to phenothiazines.
Conclusions:
- Sultopride is a highly effective and rapidly acting therapeutic option for managing acute episodes of chronic psychosis.
- Sultopride offers a significant advantage over traditional phenothiazine treatments in terms of both efficacy and speed of response.